miR-652-3p as potential biomarker in the early diagnosis of chemotherapy-induced cardiotoxicity

14 April 2024 (08:30 - 13:50)

Organised by:

About the speaker

Ms Marta Vilar Sanchez

Health Research Institute of Santiago de Compostela, Santiago de Compostela (Spain)

6 More presentations in this session

Presentation thumbnail

LncRNAs in response to endoplasmic reticulum stress: novel players in abdominal aorta aneurysm pathophysiology.

Mr R. Almendra-Pegueros (Barcelona, ES)

Presentation thumbnail

Exploring the therapeutic potential of cannabidiol and its carboxylic acid in low-grade inflammation and atherosclerosis progression

Associate Professor M. Maly (Prague, CZ)

Presentation thumbnail

Standard-of-care combination treatment rescues GFR decline and cardiac damage in a novel cardiovascular-kidney-metabolic syndrome mouse model with chronic kidney disease and HFpEF

Doctor A. Van Koppen (Den Haag, NL)

Presentation thumbnail

Cold storage of ultrathin cardiac slices to preserve the native electrophysiological response to physiological stimuli

Miss C. Lopez Andres (Zaragoza, ES)

Presentation thumbnail

The pro-atherogenic effects of CXCL5 haploinsufficiency

Ms R. Sanchez-Hodge (Chapel Hill, US)

Access the full session

Session thumbnail

Late-breaking science poster session

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

14 April 2024 08:30 CET

You may be interested in

Webinar

Biomarkers of clinical utility in cardiovascular disease

Congress Presentation

A proteo-genomic discovery approach to identify markers of early heart failure

Congress Session

From genetic signatures to clinical implications

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources